Artificial Intelligence / Machine Learning

May 14, 2025 In Artificial Intelligence / Machine Learning, DNA and RNA Polymer Research, Drug Delivery, Drug Discovery, Healthcare Big Data, Precision and Personalized Medicine By Bobby N

The Future of mRNA Is Personal: How BIOMED Sees mRNA as a Catalyst for Precision and Personalized Medicine.

mRNA rose to global prominence during the COVID-19 pandemic. However, we believe mRNA’s most significant contribution is just beginning. At its core, messenger RNA (mRNA) technology is about sending precise biological instructions to the body; a concept perfectly aligned with our mission at BIOMED: delivering personalized, precision medicine built on the unique profiles of real

April 27, 2025 In 3D Bioprinting, Artificial Intelligence / Machine Learning, Cannabis Research, Drug Delivery, Healthcare Big Data, Precision and Personalized Medicine By Bobby N

medibles, a BIOMED company, Partners with the NIH All of Us Research Program to advance the Future of Personalized and Precision Medicine

At medibles, we believe the future of medicine is precise and personalized. Today, we’re excited to share a significant step forward in that vision. Medibles, the personalized health and wellness platform developed by BIOMED Inc., is proud to announce our participation in the National Institutes of Health’s (NIH) All of Us Research Program. This partnership

February 10, 2023 In 3D Bioprinting, Artificial Intelligence / Machine Learning, Precision and Personalized Medicine By Bobby N

BIOMED, Chosen As A Top Ten Finalists For The MedTech Color 2023 Pitch Competition

Today, Los Angeles, February 10, 2023 /PRNewswire/ — BIOMED, the leading next-generation healthcare platform, was chosen as one of the top ten finalists for the MedTech Color 2023 Pitch Competition. MedTech Color (MTC) is a nonprofit organization that aims to advance the representation of persons of color in the Medtech industry. The 2023 chosen entries